Immutep Ltd Files Routine 6-K Disclosure
Ticker: PRRUF · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-private-issuer, routine-filing
Related Tickers: IMPP
TL;DR
Immutep (IMPP) filed a 6-K, standard disclosure, no major news.
AI Summary
Immutep Limited filed a Form 6-K on October 13, 2025, reporting as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is based in Sydney, Australia, and operates in the pharmaceutical preparations sector. This filing does not contain specific financial or operational updates but serves as a routine disclosure.
Why It Matters
This filing indicates Immutep Limited is meeting its ongoing disclosure obligations as a publicly traded company, which is important for maintaining transparency with investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not contain new material information that would inherently increase risk.
Key Players & Entities
- Immutep Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- October 13, 2025 (date) — Filing date
- Sydney, Australia (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the issuer makes or is required to make public pursuant to the laws of the issuer's home country or jurisdiction, or which it furnishes or makes public to its security holders.
When was Immutep Limited previously known by another name?
Immutep Limited was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
Where is Immutep Limited's principal executive office located?
Immutep Limited's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What is Immutep Limited's fiscal year end?
Immutep Limited's fiscal year end is June 30.
Does Immutep Limited file annual reports under Form 20-F or Form 40-F?
Immutep Limited indicates it files annual reports under Form 20-F.
Filing Stats: 255 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2025-10-14 06:02:11
Filing Documents
- d94471d6k.htm (6-K) — 9KB
- d94471dex991.htm (EX-99.1) — 10KB
- g94471g1013155222405.jpg (GRAPHIC) — 3KB
- g94471g1013155222500.jpg (GRAPHIC) — 1KB
- 0001193125-25-237841.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 13, 2025 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer